Edwards Lifesciences Corporation (EW) financial statements (2020 and earlier)

Company profile

Business Address ONE EDWARDS WAY
IRVINE, CA 92614
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,5179571,3381,2711,2251,439937
Cash and cash equivalents1,179714818930718654420
Short-term investments338242519341506785517
Receivables544457422366315288303
Inventory, net of allowances, customer advances and progress billings641607555397340297309
Inventory641607555397340297309
Prepaid expense59546146454947
Deferred tax assets    6433
Other current assets1681321171129412272
Other undisclosed current assets56804149293726
Total current assets:2,9842,2872,5322,2402,0482,2951,726
Noncurrent Assets
Operating lease, right-of-use asset80
Property, plant and equipment1,060868680580483443422
Long-term investments and receivables58650656753238424729
Long-term investments58650656753238024122
Accounts and financing receivable, after allowance for credit loss    467
Intangible assets, net (including goodwill)1,5041,4551,595831834399443
Goodwill1,1681,1121,127626628376385
Intangible assets, net (excluding goodwill)3373434682052052357
Deferred income tax assets172
Other noncurrent assets102341091231314935
Deferred tax assets, net  2041819270
Other undisclosed noncurrent assets 174214    
Total noncurrent assets:3,5043,0373,1642,2702,0111,230999
TOTAL ASSETS:6,4885,3245,6964,5104,0593,5242,725
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities64749656241014114056
Accounts payable18013411797645848
Accrued liabilities11710498916373 
Employee-related liabilities296226249216   
Taxes payable53319861597
Debt26 598    
Derivative instruments and hedges, liabilities642534317
Restructuring reserve1708 198
Estimated litigation liability20197158642
Business combination, contingent consideration, liability  52   
Deferred tax liabilities    87
Other undisclosed current liabilities187180144111306272264
Total current liabilities:9028771,403533476434346
Noncurrent Liabilities
Long-term debt and lease obligation653594438822600598593
Long-term debt, excluding current maturities594594438822600598593
Operating lease, liability59
Liabilities, other than long-term debt548454504536480300227
Liability for uncertainty in income taxes172125165230195195126
Other liabilities203150147306285106100
Business combination, contingent consideration, liability173179193   
Total noncurrent liabilities:1,2011,0479431,3591,080899820
Total liabilities:2,1031,9242,3461,8911,5561,3331,166
Stockholders' equity
Stockholders' equity attributable to parent4,1483,1402,9562,6192,5032,1911,559
Common stock218215212243239129126
Treasury stock, value(1,279)(1,015)(252)(2,499)(1,837)(1,557)(1,256)
Additional paid in capital1,6231,3841,1671,168947878671
Accumulated other comprehensive loss(156)(139)(133)(198)(183)(101)(28)
Retained earnings3,7422,6951,9623,9063,3372,8422,046
Total stockholders' equity:4,1483,1402,9562,6192,5032,1911,559
Other undisclosed liabilities and equity237259394    
TOTAL LIABILITIES AND EQUITY:6,4885,3245,6964,5104,0593,5242,725

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues4,3483,7233,4352,9642,4942,3232,046
Revenue, net3,4352,9642,4942,3232,046
Cost of revenue(1,114)(939)(875)(797)(617)(630)(522)
Cost of goods and services sold(1,114)(939)(875)(797)(617)(626)(522)
Other undisclosed gross profit     4 
Gross profit:3,2342,7832,5602,1661,8771,6971,523
Operating expenses(2,028)(1,925)(1,464)(1,381)(1,234)(1,209)(1,033)
Other operating income (expense), net
(Other Nonrecurring (Income) Expense)
(65)(116)(60)(35) (71)67
Other undisclosed operating income66     
Operating income:1,1477481,036751643417557
Nonoperating income4036126333
Investment income, nonoperating32322011865
Loss on contract termination     (1) 
Foreign currency transaction loss, before tax    (5)(2)(2)
Other nonoperating income (expense)84(8)(5)   
Interest and debt expense(21)(30)(23)(19)(17)(17)(10)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 710 (6)740(35)
Income from continuing operations before income taxes:1,1677611,0357386221,144515
Income tax expense(120)(39)(451)(168)(128)(333)(124)
Net income available to common stockholders, diluted:1,047722584570495811392

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:1,047722584570495811392
Other comprehensive income (loss) (16)32  (6) 
Comprehensive income:1,047706616570495806392
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(18)1834(16)(82)(68)10
Comprehensive income, net of tax, attributable to parent:1,029724649554413738402

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: